Reneo Pharmaceuticals Inc (RPHM)
1.51
0.00 (0.00%)
USD |
NASDAQ |
Jul 03, 16:00
Reneo Pharmaceuticals Net Income (Annual): -77.39M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -77.39M |
December 31, 2022 | -51.96M |
December 31, 2021 | -39.77M |
Date | Value |
---|---|
December 31, 2020 | -19.46M |
December 31, 2019 | -12.44M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-77.39M
Minimum
2023
-12.44M
Maximum
2019
-40.20M
Average
-39.77M
Median
2021
Net Income (Annual) Benchmarks
Alimera Sciences Inc | -20.13M |
NovaBay Pharmaceuticals Inc | -9.64M |
Palatin Technologies Inc | -27.54M |
iBio Inc | -65.01M |
Theriva Biologics Inc | -18.35M |